Metabolic Diseases Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Metabolic Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes

Diet, HealthyPrediabetesNutritional and Metabolic Diseases
Vanderbilt University30 enrolled1 locationNCT06482944
Recruiting
Not Applicable

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Heart FailureType 2 DiabetesDiabetic Cardiomyopathy+1 more
University of Texas Southwestern Medical Center300 enrolled1 locationNCT06593327
Recruiting
Not Applicable

The Satiety Control Optimization by Nutritional Enhancement Study

Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease
University College Cork24 enrolled1 locationNCT07420023
Recruiting
Not Applicable

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

Time Restricted EatingHigh-intensity Interval TrainingObesity and Type 2 Diabetes+1 more
Syracuse University40 enrolled1 locationNCT07215533
Recruiting

Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease

Parkinson DiseaseNutritional and Metabolic DiseasesSugar Intake
University Hospital Schleswig-Holstein50 enrolled1 locationNCT05998772
Recruiting
Phase 4

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Genetic PredispositionType 2 DiabetesMetabolic Diseases
Massachusetts General Hospital125 enrolled1 locationNCT06003153
Recruiting

Cardiometabolic evalUation REgistry of Heart Failure

Heart FailureMetabolic DiseasesMetabolic Cardiovascular Syndrome
Ruijin Hospital5,000 enrolled1 locationNCT06939985
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980